Era Mandiri Cemerlang Tbk PT
PT Era Mandiri Cemerlang Tbk produces and supplies seafood products in Indonesia. It offers mahi-mahi, tuna, swordfish, oilfish, red snapper, grouper, black pomfret, octopus, spanish mackerel, shark, wahoo, goldband snapper, leather jacket, emperor, parrotfish, milkfish, and other fish products. The company also exports its products to the United States, Mexico, Ecuador, German, Holland, Poland, … Read more
Era Mandiri Cemerlang Tbk PT (IKAN) - Total Liabilities
Latest total liabilities as of September 2025: Rp54.14 Billion IDR
Based on the latest financial reports, Era Mandiri Cemerlang Tbk PT (IKAN) has total liabilities worth Rp54.14 Billion IDR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Era Mandiri Cemerlang Tbk PT - Total Liabilities Trend (2017–2024)
This chart illustrates how Era Mandiri Cemerlang Tbk PT's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Era Mandiri Cemerlang Tbk PT Competitors by Total Liabilities
The table below lists competitors of Era Mandiri Cemerlang Tbk PT ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
OLB Group Inc
NASDAQ:OLB
|
USA | $6.99 Million |
|
CASI Pharmaceuticals Inc
NASDAQ:CASI
|
USA | $53.05 Million |
|
NSBBF
OTCQB:NSBBF
|
USA | $56.48 Million |
|
Anik Industries Limited
NSE:ANIKINDS
|
India | ₹659.93 Million |
|
Noronex Ltd
AU:NRX
|
Australia | AU$1.22 Million |
|
Carmell Therapeutics Corporation
NASDAQ:CTCX
|
USA | $7.14 Million |
|
XWELL Inc.
NASDAQ:XWEL
|
USA | $18.68 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down Era Mandiri Cemerlang Tbk PT's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.04 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.72 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Era Mandiri Cemerlang Tbk PT's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Era Mandiri Cemerlang Tbk PT (2017–2024)
The table below shows the annual total liabilities of Era Mandiri Cemerlang Tbk PT from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Rp63.95 Billion | -5.26% |
| 2023-12-31 | Rp67.50 Billion | +27.65% |
| 2022-12-31 | Rp52.88 Billion | -9.39% |
| 2021-12-31 | Rp58.36 Billion | -7.96% |
| 2020-12-31 | Rp63.40 Billion | +1.81% |
| 2019-12-31 | Rp62.28 Billion | -10.31% |
| 2018-12-31 | Rp69.44 Billion | +20.25% |
| 2017-12-31 | Rp57.75 Billion | -- |